Ephar

Business Services · Brazil · 51-200 Employees

View Company Info for Free

Overview

Headquarters

530 Crimeia Leste, Goinia, Go, 74660-205...

Phone Number

+55 6236456797

Revenue

$5.2 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Ephar

EPHAR is a pharmaceutical excellence institute that focuses on quality as its driving force, providing high-quality testing and analysis services to pharmaceutical companies. They assist in maintaining product integrity through personalized analyses tailored to client needs, ensuring safety and efficacy in the ever-evolving medical landscape. EPHAR is equipped with advanced analytical structures and is recognized by ANVISA for its capabilities in evaluating oncological medications and other pharmaceutical products. Their mission is centered on the relentless pursuit of excellence, quality, and timely delivery of services.Explore more
Ephar's Social MediaPopular SearchesEpharEPHAR - Instituto de Excelência FarmacêuticaSIC Code 87,873NAICS Code 54,541Show more

Ephar Org Chart

PhoneEmail
AL
Brazil flag for contact location.

Diretora Comercial

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AL
Brazil flag for contact location.

Supervisora Do Comercial Técnico

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Ephar your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Ephar is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Ephar is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ephar.

Ephar Tech Stack

A closer look at the technologies used by Ephar

Top Business Services Companies

Frequently Asked Questions Regarding Ephar

What is Ephar's official website?
Ephar's official website is www.ephar.com.br
What is Ephar's Revenue?
Ephar's revenue is $5.2 Million
What is Ephar's SIC code?
Ephar's SIC: 87,873
What is Ephar's NAICS code?
Ephar's NAICS: 54,541
How many employees does Ephar have?
Ephar has 51-200 employees
What industry does Ephar belong to?
Ephar is in the industry of: Business Services, Research & Development
What technology does Ephar use?
Some of the popular technologies that Ephar uses are: Sentry, F5 BIG-IP Platform, Sectigo, The USERTRUST Network
How do I contact Ephar?
Ephar contact info: Phone number: +55 6236456797 Website: www.ephar.com.br
What does Ephar do?

EPHAR is a pharmaceutical excellence institute that focuses on quality as its driving force, providing high-quality testing and analysis services to pharmaceutical companies. They assist in maintaining product integrity through personalized analyses tailored to client needs, ensuring safety and efficacy in the ever-evolving medical landscape. EPHAR... is equipped with advanced analytical structures and is recognized by ANVISA for its capabilities in evaluating oncological medications and other pharmaceutical products. Their mission is centered on the relentless pursuit of excellence, quality, and timely delivery of services.Read More

What are Ephar social media links?
Ephar Linkedin page
Is Ephar a public company?
Ephar is private company therefore does not currently have an official ticker symbol
See more information about Ephar

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.